Acquisition & Growth Consulting for Healthcare Operators in Irving, TX

Irving sits at 256,000 people inside the city limits and functions as one of the most strategically located healthcare submarkets in the DFW metro. DFW International Airport on the western edge, the Las Colinas business district anchoring the center, and the I-35E corridor on the east connecting to Dallas proper. Baylor Scott & White Medical Center Irving on Rochelle Road is the dominant inpatient anchor, with a strong outpatient and specialty footprint feeding off it. Methodist Las Colinas Medical Center sits closer to the corporate core and serves a meaningfully different patient mix — younger, more commercially insured, more elective volume.

The ambulatory and specialty layer is where most of the deal activity actually lives. Independent gastroenterology, dermatology, ophthalmology, orthopedics, and primary-care groups have been consolidating across the mid-cities for the better part of a decade, often with PE-backed platforms based out of Dallas, Plano, or Houston rolling them up one at a time. Las Colinas has its own concentration of urgent care, occupational health, and concierge primary care tied to the corporate population — ExxonMobil, Caterpillar, Kimberly-Clark, McKesson, and Christus all maintain meaningful Irving footprints, and several have direct-contract employer health arrangements that change the economics of any practice serving them.

MSG is 308 miles southeast of Irving on US-287 and I-45 — about four and a half hours by road. We structure Irving healthcare engagements with a 3-day on-site immersion at kickoff, on-site presence at every major operational inflection point (target site visits during diligence, integration day-one, post-90 review), and a weekly working cadence in between. Owner-operators in Irving healthcare have generally seen enough out-of-market consultants fly in for kickoffs and disappear that what they want from MSG is a Gulf Coast operator partner who understands the difference between selling to a strategic versus a sponsor and is willing to be on the ground when the work actually happens.

Discovery for an Irving healthcare growth or acquisition engagement starts with the financial and operational reality of the operator's current platform. We pull three years of financial detail at the practice and entity level — collections by payer, by provider, by location, by service line. We map your patient population by zip and submarket because the difference between a Las Colinas patient and a south Irving patient shows up in collections, no-show rate, and procedure mix. We look at your provider productivity in actual wRVUs and in revenue per encounter, and we run those numbers against MGMA benchmarks for the specialty. We sit through a clinic day with the practice manager, and we sit through a weekend on-call cycle with whoever covers it.

If the engagement is sell-side — owner preparing the practice for a strategic or sponsor sale — we spend the next 90 days on quality of earnings preparation, owner-comp normalization, EBITDA bridge construction, and operational hygiene that materially affects valuation. We work with your CPA, not around them. We help you understand what a Dallas-based PE platform will pay versus what a strategic health system will pay, and what the structural differences in those deals mean for your post-close life. We help you decide whether you want a rollover stake or a clean exit, and we help you understand the implications of either.

If the engagement is buy-side — owner growing through acquisition — we build the target list against your strategic geography, run preliminary diligence against payer mix and provider stability, structure LOIs that protect you, and run integration playbooks for the first 90 days post-close. The integration phase is where most healthcare acquisitions destroy value, and it's where MSG spends the most operational energy. We have lived through enough multi-site rollups to know that the EHR migration plan, the credentialing-bridge strategy, the payer contract assignment process, and the staff retention playbook are the difference between a deal that creates value and one that bleeds it.

Healthcare acquisition and growth in 2026 looks different than it did three years ago. Interest rates have reset deal pricing. Sponsor-backed platforms that were paying 10-12x EBITDA for specialty practices in 2021 are paying 7-9x now, and the deal terms — earn-out structures, rollover requirements, restrictive covenants — have tightened across the board. Owner-operators considering a sale today are walking into a market that demands cleaner financials, more defensible patient-attribution data, and more honest provider-stability narratives than the 2021 frenzy required.

Irving specialty practices have a specific advantage in this market that gets underweighted by out-of-state buyers — payer mix. The Las Colinas corporate population skews younger and more commercially insured than the DFW average, and practices with meaningful exposure to that population trade at a premium to comparable-revenue practices in heavier-Medicaid submarkets. The work in due diligence preparation is to make that payer-mix advantage legible to buyers. Most owner-operators we meet undersell this. They know their book intuitively but haven't built the data layer that proves it.

The consolidation pattern in Irving is also specific. Dermatology has been heavily rolled up. Gastro is mid-cycle. Ophthalmology and orthopedics are still highly fragmented and getting active interest. Primary care is bifurcating between value-based-care platforms (Oak Street, ChenMed-style models) and concierge models tied to the corporate population. Where your specialty sits in that consolidation cycle changes the negotiating leverage materially. We help owners understand whether they're early, in the middle, or late, and what that means for timing and pricing.

MSG is an operator-consulting firm that has built and shipped production software businesses — ServiceStorm, MFGBase, LocalAISource. That operator background changes how we work healthcare deals. We have lived the difference between a clean integration and a messy one. We know what an EHR migration looks like when it's done right and what it looks like when it's not. We know the difference between a payer contract that assigns cleanly and one that triggers a re-credentialing cycle that wrecks 90 days of cash flow.

We operate as your seat at the table, not as a sell-side broker chasing a transaction fee. Most owner-operators have been pitched by Dallas-based investment bankers and PE-aligned advisory firms whose incentives are to close any deal at any price. MSG's incentive structure is the opposite — we work on engagement fees, we don't take success fees on transaction value, and our reputation depends on owners ending up better off after working with us than they would have on their own. That alignment matters most in the moments where a banker would push you to close and we would tell you to walk.

And we're a Gulf Coast firm willing to put real on-the-ground time into Irving deals. Beaumont to Irving is a four-and-a-half-hour drive on US-287 and I-45, and we structure engagements around meaningful site presence — kickoff immersion, target diligence visits, integration day-one, post-90 review. That's different from a Dallas advisory firm running multiple concurrent deals out of a downtown office, and operators tend to feel the difference inside the first month.